Alyeska Investment Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-134,277
| Closed | -$258K | – | 547 |
|
|
2025
Q1 | $258K | Buy |
+134,277
| New | +$258K | ﹤0.01% | 480 |
|
|
2018
Q3 | – | Sell |
-97,734
| Closed | -$975K | – | 363 |
|
|
2018
Q2 | $975K | Sell |
97,734
-4,701
| -5% | -$46.9K | 0.01% | 369 |
|
|
2018
Q1 | $976K | Sell |
102,435
-925
| -0.9% | -$8.81K | 0.01% | 359 |
|
|
2017
Q4 | $1.54M | Sell |
103,360
-23,914
| -19% | -$356K | 0.01% | 328 |
|
|
2017
Q3 | $2.5M | Buy |
127,274
+2,274
| +2% | +$44.7K | 0.02% | 317 |
|
|
2017
Q2 | $1.8M | Buy |
+125,000
| New | +$1.8M | 0.02% | 337 |
|